Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...

At FDA, full vaccine approval is the gold standard. The agency was on track to sign off on Novavax’s license by its April 1 ...

A former FDA commissioner and a former Institute of Medicine president are teaming up to create the Vaccine Integrity Project ...

Some key public health figures are taking an extraordinary step to try to shore up U.S. vaccination policy, feared to be ...

Over the next four months, the Vaccine Integrity Project will hold information-gathering sessions with medical associations, public health organizations, state health officials, vaccine manufacturers, ...

The FDA is asking Novavax for a non-mandatory postmarketing commitment to produce additional clinical data for its ...

The new FDA chief reiterated his commitment to speeding up drug approval processes and run the agency by “gold standard ...

Concerned that the nation’s health leadership is casting unfounded doubt on the safety of well-studied vaccines and may take ...

Germany's Merck KGaA is nearing a roughly $3.5 billion deal for SpringWorks Therapeutics , the Wall Street Journal reported ...

Novavax’s vaccine, which is the only protein-based COVID-19 vaccine, is awaiting for its full approval. Once approved, it ...

In his inaugural speech upon taking over as secretary of the Department of Health and Human Services, Robert F. Kennedy Jr.

Whooping cough cases are rising, and doctors are bracing for yet another tough year. There have been 8,485 cases reported in ...